ASMB News and Press, Assembly Biosciences Inc. From 02/12/24

2024-02-12 08:02:10 ET Assembly Biosciences Inc (ASMB) announced stock split at a ratio of 1-for-12 on 2024-02-12 ... Full story available on KlickAnalytics.com

2024-02-08 08:51:59 ET More on Assembly Biosciences Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Biosciences Read the full article on Seeking Alpha For...

– Assembly Bio common stock expected to begin trading on a split-adjusted basis on February 12, 2024 – SOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antivir...

2024-01-31 08:24:06 ET Guardion Health Sciences  ( GHSI ) +84% Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv Brand and Business to Doctor’s Best Inc Ensysce Biosciences  ( ENSC ) +33% Announces Positive End of Phase 2 M...

Four development candidates anticipated to be in the clinic by the end of 2024, reflecting expansion of R&D portfolio across herpesviruses and hepatitis B and D viruses Initial clinical data anticipated by end of year from first-in-human study of long-acting helicase-primase inhibit...

2023-11-24 09:50:02 ET Penny stocks, defined as stocks trading under $5 per share , offer investors the allure of exponential growth. As an inherently volatile market sector, penny stocks can rapidly surge on positive news, rumors, and breakthroughs – allowing traders to pote...

--Poster highlights potential of oral small molecule IFNAR agonist program to engage the IFNα pathway through a liver-focused approach to improve tolerability-- SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology c...

Assembly Biosciences Inc. (ASMB) is expected to report $-0.23 for Q3 2023

2023-11-08 17:18:45 ET More on Assembly Biosciences Gilead and Assembly Bio ink deal for antiviral drugs Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Bioscienc...

Established partnership with Gilead Sciences to advance differentiated treatments for herpesviruses, HBV, HDV and beyond Now anticipate four development candidates from expanded pipeline in clinical development by the end of 2024 Named Anuj Gaggar, MD, PhD, as chief medical office...